Related Experiment Video
Updated: Oct 25, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Differences Between Men and Women with Chronic Obstructive Pulmonary Disease
1Respiratory Group, The George Institute for Global Health, Sydney, Level 5, 1 King Street, Newtown, New South Wales 2042 Australia; UNSW Medicine and Health, UNSW Sydney, NSW, Australia; Concord Clinical School, University of Sydney, NSW, Australia.
Differences in chronic obstructive pulmonary disease (COPD) between men and women are significant but understudied. Understanding these sex-based variations is crucial for timely diagnosis and tailored treatments.
Area of Science:
- Pulmonology
- Sex-based medicine
- Chronic respiratory diseases
Background:
- Chronic obstructive pulmonary disease (COPD) exhibits notable sex-based differences in risk factors, symptoms, and outcomes.
- These disparities remain inadequately explored, impacting diagnosis and treatment strategies.
- Underrepresentation of women in clinical trials and a focus on tobacco-related COPD limit comprehensive understanding.
Purpose of the Study:
- To highlight the significant, yet under-explored, differences between males and females regarding chronic obstructive pulmonary disease (COPD).
- To emphasize the need for tailored therapeutic approaches based on sex-specific characteristics in COPD management.
- To advocate for increased research and data collection on sex-based variations in COPD.
Main Methods:
- Review and synthesis of existing literature on sex differences in COPD.
- Analysis of clinical manifestations, risk factor vulnerability, and treatment outcomes in men versus women.
- Identification of research gaps, particularly concerning underrepresented populations and non-tobacco phenotypes.
Main Results:
- Significant variations exist between men and women in COPD risk, symptom presentation, and disease progression.
- Delayed diagnosis and treatment are prevalent issues for both sexes, exacerbated by a lack of sex-specific data.
- Women are often underrepresented in clinical trials, limiting evidence for optimal, tailored interventions.
Conclusions:
- There is a critical need to address the sex-based disparities in COPD research and clinical practice.
- Targeted and individualized treatment strategies are essential for improving COPD outcomes in both men and women.
- Further research focusing on underrepresented groups and diverse COPD phenotypes is required to optimize patient care.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

